{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:00:32Z","timestamp":1762506032731},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.regpep.2012.12.005","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T21:35:25Z","timestamp":1358199325000},"page":"1-6","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial"],"prefix":"10.1016","volume":"182","author":[{"given":"Alireza","family":"Esteghamati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Noshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soghra","family":"Rabizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Zandieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manouchehr","family":"Nakhjavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2012.12.005_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2012.12.005_bb0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1079\/PNS200194","article-title":"Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ","volume":"60","author":"Trayhurn","year":"2001","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.regpep.2012.12.005_bb0015","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1210\/jc.2008-1613","article-title":"Adipocytokines and the metabolic complications of obesity","volume":"93","author":"Rasouli","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.12.005_bb0020","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","article-title":"The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity","volume":"15","author":"Wisse","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.regpep.2012.12.005_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/156720507780362065","article-title":"The epidemiology of adiposity and dementia","volume":"4","author":"Whitmer","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.regpep.2012.12.005_bb0215","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.2000.278.1.E1","article-title":"The adipoinsular axis: effects of leptin on pancreatic beta-cells","author":"Kieffer","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.12.005_bb0220","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","author":"Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.12.005_bb0040","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.12.005_bb0225","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/db06-1506","article-title":"Omentin plasma levels and gene expression are decreased in obesity","author":"DeSouzaBatista","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.12.005_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2010.01.013","article-title":"Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes","volume":"88","author":"Pan","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.regpep.2012.12.005_bb0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/db07-0990","article-title":"Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.12.005_bb0060","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.atherosclerosis.2011.08.017","article-title":"Circulating omentin is associated with coronary artery disease in men","volume":"219","author":"Shibata","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.regpep.2012.12.005_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.diabres.2011.03.001","article-title":"Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome","volume":"93","author":"Liu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.regpep.2012.12.005_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/09513590.2010.487583","article-title":"Association of plasma leptin levels and insulin resistance in diabetic women: a cross-sectional analysis in an Iranian population with different results in men and women","volume":"27","author":"Nakhjavani","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.regpep.2012.12.005_bb0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.arcmed.2011.05.005","article-title":"Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects","volume":"42","author":"Esteghamati","year":"2011","journal-title":"Arch Med Res"},{"issue":"Suppl. 1","key":"10.1016\/j.regpep.2012.12.005_bb0080","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.2337\/diabetes.53.2007.S152","article-title":"Leptin effects on pancreatic beta-cell gene expression and function","volume":"53","author":"Seufert","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.12.005_bb0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.regpep.2012.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2008.05.060","article-title":"Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease","volume":"52","author":"Martin","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.regpep.2012.12.005_bb0235","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.2337\/dc09-0125","volume":"32","author":"Cobitz","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.12.005_bb0100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2009.49","article-title":"Is it possible to reduce cardiovascular risk with glucose-lowering approaches?","volume":"5","author":"Gerstein","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.regpep.2012.12.005_bb0105","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-154-9-201105030-00336","article-title":"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations","volume":"154","author":"Bennett","year":"2011","journal-title":"Ann Intern Med"},{"issue":"Suppl. 1","key":"10.1016\/j.regpep.2012.12.005_bb0240","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2012.12.005_bb0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cyto.2012.02.005","article-title":"The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels","author":"Akbarzadeh","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.regpep.2012.12.005_bb0120","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1464-5491.2008.02568.x","article-title":"Decreased plasma omentin-1 levels in type 1 diabetes mellitus","volume":"25","author":"Tan","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.regpep.2012.12.005_bb0125","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1210\/jc.82.4.1293","article-title":"The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure","volume":"82","author":"Kennedy","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.12.005_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-7-27","article-title":"Circulating omentin concentration increases after weight loss","volume":"7","author":"Moreno-Navarrete","year":"2010","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.regpep.2012.12.005_bb0255","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.2337\/db10-0124","article-title":"Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome","author":"Tan","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.12.005_bb0260","first-page":"289","article-title":"Effect of treatment with metformin on omentin-1, ghrelin and other biochemical, clinical features in PCOS patients","author":"Shaker","year":"2010","journal-title":"Oman Med J"},{"key":"10.1016\/j.regpep.2012.12.005_bb0265","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.diabres.2011.02.030","article-title":"Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus","author":"Yan","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.regpep.2012.12.005_bb0150","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2337\/diabetes.54.5.1459","article-title":"Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study","volume":"54","author":"Karlsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.12.005_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00365521.2010.516452","article-title":"Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease","author":"Yilmaz","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.regpep.2012.12.005_bb0160","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: the role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2012.12.005_bb0165","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.12.005_bb0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0028-1091984","article-title":"Current and emerging therapies in nonalcoholic fatty liver disease","volume":"28","author":"Kashi","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.regpep.2012.12.005_bb0175","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1111\/j.1467-789X.2010.00840.x","article-title":"Ten years of leptin replacement therapy","volume":"12","author":"Paz-Filho","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.regpep.2012.12.005_bb0275","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.12.005_bb0185","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.ATV.18.6.928","article-title":"Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk","volume":"18","author":"Leyva","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.regpep.2012.12.005_bb0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-2125.2009.03372.x","article-title":"Metformin increases plasma ghrelin in Type 2 diabetes","volume":"68","author":"Doogue","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.regpep.2012.12.005_bb0195","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1463-1326.2008.00880.x","article-title":"Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients","volume":"10","author":"Miyazaki","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.regpep.2012.12.005_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12020-008-9058-x","article-title":"Arterial elasticity and plasma levels of adiponectin and leptin in type 2 diabetic patients treated with thiazolidinediones","volume":"33","author":"Oz","year":"2008","journal-title":"Endocrine"},{"key":"10.1016\/j.regpep.2012.12.005_bb0205","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1248\/bpb.33.963","article-title":"Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL\/6J mice","volume":"33","author":"Matsui","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.regpep.2012.12.005_bb0210","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2265.2006.02658.x","article-title":"Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus","volume":"65","author":"Sharma","year":"2006","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011513000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011513000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T18:09:09Z","timestamp":1714846149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011513000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":42,"alternative-id":["S0167011513000062"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2012.12.005","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}